BioInfra Co., Ltd.

BioInfra is a contract research organization for phase 1 clinical trials. The company provides clinical, which undertakes clinical trials for new drug development approval (Phase I-III) and late clinical trials.

Its portfolio also includes immunoassay, which performs pharmacokinetic, toxicokinetic, and biomarker analysis of polymer biopharmaceuticals, and testing and inspection, which provides finished drug product quality inspection, comparative dissolution testing, and long-term stability testing.

It also specializes in bioequivalence testing of generic drugs, phase 1 clinical trials for new and improved drugs; and sample analysis services for new drug substances. Founded in 2007, the company is based in Yongin-si, South Korea.